Western Blot Assay for Antibodies to Borrelia burgdorferi, 1st Edition
This document addresses technical and interpretive considerations for use of Western blot assays that detect antibodies to Borrelia burgdorferi and other Borrelia species that cause Lyme disease.
This document is available in electronic format only.
Chairholder: Alan G. Barbour, M.D.
Date of Publication: October 1, 2000
Order Code PDF: M34AE
ISBN Number: 1-56238-415-5
Order Code Print: print not available
M34 Additional Details
If interested in ordering larger quantities of this document in print, please contact us here.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of January 2017. Because of its value to the laboratory community, it is being retained in CLSI’s library.